OTC Markets OTCPK - Delayed Quote USD
Vincerx Pharma, Inc. (VINC)
0.0602
+0.0112
+(22.76%)
At close: June 4 at 3:28:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -3.69 | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.8 | -- | -4.33 | -3.4 |
| EPS Actual | -6.75 | -3.69 | -3.4 | -15.22 |
| Difference | -2.95 | -- | 0.93 | -11.82 |
| Surprise % | -77.68% | -- | 21.54% | -347.65% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VINC | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Maintains | Leerink Partners: Outperform to Outperform | 10/8/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 4/9/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 4/1/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/7/2023 |
| Maintains | Chardan Capital: Buy | 11/17/2022 |
| Maintains | SVB Leerink: Outperform | 8/12/2022 |
Related Tickers
SCPX Scorpius Holdings, Inc.
0.0420
+5.00%
SYRS Syros Pharmaceuticals, Inc.
0.0251
-2.90%
LIXT Lixte Biotechnology Holdings, Inc.
1.3900
-1.42%
IVBIY Innovent Biologics Inc.
29.00
+11.07%
SPRC SciSparc Ltd.
0.3030
-1.72%
PXMD PaxMedica, Inc.
0.0001
0.00%
PHVS Pharvaris N.V.
16.62
-3.82%
TSBX Turnstone Biologics Corp.
0.3465
+0.09%
RLYB Rallybio Corporation
0.3760
+27.85%
ENSC Ensysce Biosciences, Inc.
2.3800
+3.48%